Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Instadose Pharma Corp. INSD

Set alert

Price alert · INSD

All alert types
0.00 USD 0.00 0.00%

At close · Oct 29

0.0001 Day range 0.0001
0.0001 52-week range 0.0011
YTD
0.00%
1 year
-90.91%
Open
0.0001
Prev close
0.0001
Mkt cap
53.19K
Vol
944
Avg vol
4
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for INSD has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-5.65 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5127×
FY 2016: -65.7×FY 2017: -197×FY 2018: -246×FY 2019: -197×FY 2020: -328×FY 2021: -5127×
FY 2016 5y median -246× FY 2021
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2049×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
P/B -14532×
FY 2016: 13.4×FY 2017: -477×FY 2018: -166×FY 2019: -75.8×FY 2020: -69.1×FY 2021: -14532×
FY 2016 5y median -166× FY 2021
P/FCF -22285302×
FY 2016: 0.0×FY 2017: -276×FY 2018: -1778×FY 2019: 26712×FY 2020: -89196×FY 2021: -22285302×
FY 2016 5y median -1778× FY 2021
EV/EBITDA -18378×
FY 2016: -60.0×FY 2017: -232×FY 2018: -237×FY 2019: -320×FY 2020: -1258×FY 2021: -18378×
FY 2016 5y median -320× FY 2021
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2058×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
FCF Yield -0.0%
FY 2016: 0.0%FY 2017: -0.4%FY 2018: -0.1%FY 2019: 0.0%FY 2020: -0.0%FY 2021: -0.0%
FY 2016 5y median -0.0% FY 2021

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 49.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -653.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -867.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
ROE 463.7%
FY 2016: -20.5%FY 2017: 265.5%FY 2018: 70.4%FY 2019: 39.6%FY 2020: 31.2%FY 2021: 463.7%
FY 2016 5y median 70.4% FY 2021
ROIC 372.5%
FY 2016: -17.0%FY 2017: -752.6%FY 2018: 53.0%FY 2019: 118.7%FY 2020: 12.4%FY 2021: 372.5%
FY 2016 5y median 53.0% FY 2021
ROA -19633.3%
FY 2016: -16.0%FY 2017: -2941.7%FY 2018: -23540.0%FY 2019: -45713.2%FY 2020: -39471.3%FY 2021: -19633.3%
FY 2016 5y median -23540.0% FY 2021

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 FY 2021
Operating Income -1700.8%
FY 2016: 0.0%FY 2017: -1545.9%FY 2018: 26.3%FY 2019: 1.1%FY 2020: -10.2%FY 2021: -1700.8%
FY 2016 FY 2021
EPS (diluted) -1500.0%
FY 2016: 0.0%FY 2017: 66.7%FY 2018: 20.0%FY 2019: -25.0%FY 2020: 40.0%FY 2021: -1500.0%
FY 2016 FY 2021
Free Cash Flow 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 84.5%FY 2019: 106.7%FY 2020: -129.9%FY 2021: 0.0%
FY 2016 FY 2021

Financial Health

Current Ratio 0.0×
FY 2016: 4.6×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
Quick Ratio 0.0×
FY 2016: 4.6×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021
Debt / Equity 0.0×
FY 2016: 0.2×FY 2017: -0.8×FY 2018: -0.7×FY 2019: -0.6×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median -0.6× FY 2021
Net Debt / EBITDA 0.0×
FY 2016: 5.2×FY 2017: -0.3×FY 2018: -1.0×FY 2019: -2.4×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median -0.3× FY 2021
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2016 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2016 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-11-30